N.A. Molodkina
Research Subjects
N.A. Molodkina has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Alexey Aleksandrovich Suetov
S. Fyodorov Eye Microsurgery Federal State Institution, Saint Petersburg branch, Saint Petersburg, Russian Federation
4 shared publications - Ernest Vitalievich Boiko
S. Fyodorov Eye Microsurgery Federal State Institution; I. Mechnikov North-Western State Medical University; Saint Petersburg State University
3 shared publications - A.S. Izmaylov
Saint Petersburg Branch of S.N. Fedorov National Medical Research Center "MNTK "Eye Microsurgery", Saint Petersburg, Russia
2 shared publications - Taisiia A. Doktorova
S. Fyodorov Eye Microsurgery Federal State Institution, Saint Petersburg Branch
2 shared publications
Latest Publications
- 29 October 2025
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 141 (5) , 16-22
The effect of initial conservative hypotensive therapy on the outcomes of selective laser trabeculoplasty in primary open-angle glaucoma
Objective. The effect of the type of topical hypotensive therapy on the hypotensive effect of selective laser trabeculoplasty (SLT) in primary open-angle glaucoma (POAG). Material and methods. A retrospective analysis was performed on medical records of patients who received SLT for the first time and had no prior laser or surgical glaucoma treatment. SLT was performed according to the standard protocol, with 360° trabecula treatment. Patients were divided into five subgroups based on the number of hypotensive medications used (0 to 4) and into 15 subgroups according to the combinations of medications used before SLT. Intraocular pressure (IOP) levels before and after treatment were compared, and the IOP-lowering effect of SLT was evaluated at 1 day and 1 month postoperatively. Results. The study included 808 patients (808 eyes) with POAG stages I—III, who either received no hypotensive therapy (n=54) or were on one (n=169), two (n=233), three (n=307), or four (n=45) topical hypotensive medications. The hypotensive effect differed significantly among subgroups with different numbers of medications at 1 day after SLT (F=3.18; p=0.01). The greatest effect was observed in the subgroup receiving maximum therapy (5.0±3.3 (95% confidence interval (CI) 3.9—6.1) mm Hg), which decreased by 1 month and became the lowest among all subgroups (2.6±3.0 (95% CI 1.6—3.7) mm Hg). At 1 month, differences among subgroups were not statistically significant (F=2.21; p=0.07), although the greatest effect was seen in the subgroup without therapy (4.0±2.8 (95% CI 3.2—4.8) mm Hg). The effect of SLT did not significantly differ among the 15 subgroups with different types of pre-surgical therapy at either 1 day (F=1.65; p=0.28) or 1 month (F=1.19; p=0.06) after laser treatment. Conclusion. Selective laser trabeculoplasty is an effective method for additional IOP reduction in POAG, and its hypotensive effect does not depend on the number, type, or combination of hypotensive eye drops used before laser treatment.
- 29 October 2025
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 141 (5) , 16-22
The effect of initial conservative hypotensive therapy on the outcomes of selective laser trabeculoplasty in primary open-angle glaucoma
Objective. The effect of the type of topical hypotensive therapy on the hypotensive effect of selective laser trabeculoplasty (SLT) in primary open-angle glaucoma (POAG). Material and methods. A retrospective analysis was performed on medical records of patients who received SLT for the first time and had no prior laser or surgical glaucoma treatment. SLT was performed according to the standard protocol, with 360° trabecula treatment. Patients were divided into five subgroups based on the number of hypotensive medications used (0 to 4) and into 15 subgroups according to the combinations of medications used before SLT. Intraocular pressure (IOP) levels before and after treatment were compared, and the IOP-lowering effect of SLT was evaluated at 1 day and 1 month postoperatively. Results. The study included 808 patients (808 eyes) with POAG stages I—III, who either received no hypotensive therapy (n=54) or were on one (n=169), two (n=233), three (n=307), or four (n=45) topical hypotensive medications. The hypotensive effect differed significantly among subgroups with different numbers of medications at 1 day after SLT (F=3.18; p=0.01). The greatest effect was observed in the subgroup receiving maximum therapy (5.0±3.3 (95% confidence interval (CI) 3.9—6.1) mm Hg), which decreased by 1 month and became the lowest among all subgroups (2.6±3.0 (95% CI 1.6—3.7) mm Hg). At 1 month, differences among subgroups were not statistically significant (F=2.21; p=0.07), although the greatest effect was seen in the subgroup without therapy (4.0±2.8 (95% CI 3.2—4.8) mm Hg). The effect of SLT did not significantly differ among the 15 subgroups with different types of pre-surgical therapy at either 1 day (F=1.65; p=0.28) or 1 month (F=1.19; p=0.06) after laser treatment. Conclusion. Selective laser trabeculoplasty is an effective method for additional IOP reduction in POAG, and its hypotensive effect does not depend on the number, type, or combination of hypotensive eye drops used before laser treatment.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 140 (2) , 54-62
Factors affecting the hypotensive effect of selective laser trabeculoplasty in primary open-angle glaucoma
PURPOSE This study analyzes the influence of various factors on the hypotensive effect of selective laser trabeculoplasty (SLT) in patients with primary open-angle glaucoma (POAG). MATERIAL AND METHODS A retrospective study of the SLT effect was performed in 582 patients (756 eyes; mean age — 71.9±9.5 years) with POAG stages I—III. The level of intraocular pressure (IOP) decrease was assessed at 1 day, 1, 3, 6, and 12 months after SLT. The relationship between the hypotensive effect and age, gender, glaucoma stage, initial IOP level, number and type of instilled drugs, presence of intraocular lenses, and the surgeon performing the intervention were analyzed. RESULTS In the entire sample, the hypotensive effect of SLT after 1 day was 4.1±3.4 mm Hg, after 1, 3, 6, and 12 months — 3.7±4.8; 3.5±3.8; 3.1±3.4 and 2.3±3.8 mm Hg, respectively. The hypotensive effect of SLT was most dependent on the preoperative IOP level (R>0.64, ppp<0.02). CONCLUSION SLT is an effective method of additional IOP reduction in POAG at any stage and with any hypotensive regimen. At the same time, the results of its use in real clinical practice indicate the need for more careful IOP control after the procedure, especially in eyes with POAG stage III, as well as in eyes without hypotensive therapy and on the maximum drop regimen.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 140 (2) , 54-62
Factors affecting the hypotensive effect of selective laser trabeculoplasty in primary open-angle glaucoma
PURPOSE This study analyzes the influence of various factors on the hypotensive effect of selective laser trabeculoplasty (SLT) in patients with primary open-angle glaucoma (POAG). MATERIAL AND METHODS A retrospective study of the SLT effect was performed in 582 patients (756 eyes; mean age — 71.9±9.5 years) with POAG stages I—III. The level of intraocular pressure (IOP) decrease was assessed at 1 day, 1, 3, 6, and 12 months after SLT. The relationship between the hypotensive effect and age, gender, glaucoma stage, initial IOP level, number and type of instilled drugs, presence of intraocular lenses, and the surgeon performing the intervention were analyzed. RESULTS In the entire sample, the hypotensive effect of SLT after 1 day was 4.1±3.4 mm Hg, after 1, 3, 6, and 12 months — 3.7±4.8; 3.5±3.8; 3.1±3.4 and 2.3±3.8 mm Hg, respectively. The hypotensive effect of SLT was most dependent on the preoperative IOP level (R>0.64, ppp<0.02). CONCLUSION SLT is an effective method of additional IOP reduction in POAG at any stage and with any hypotensive regimen. At the same time, the results of its use in real clinical practice indicate the need for more careful IOP control after the procedure, especially in eyes with POAG stage III, as well as in eyes without hypotensive therapy and on the maximum drop regimen.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (4) , 81-86
Vortex vein varix (clinical observations)
Varix of the vortex vein ampulla is a rare benign condition that has clinical similarities to more concerning choroidal lesions that pose a threat to vision, in particular choroidal melanoma. The article describes two clinical cases, one of which is unique due to the combination of bilateral lesion and the presence of multiple varices in one eye. A brief review of the literature on this condition is also provided.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (4) , 81-86
Vortex vein varix (clinical observations)
Varix of the vortex vein ampulla is a rare benign condition that has clinical similarities to more concerning choroidal lesions that pose a threat to vision, in particular choroidal melanoma. The article describes two clinical cases, one of which is unique due to the combination of bilateral lesion and the presence of multiple varices in one eye. A brief review of the literature on this condition is also provided.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (4)
Vortex vein varix (clinical observations)
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 138 (4)
Vortex vein varix (clinical observations)